General meetings

Documents related to general meetings of Xspray Pharma AB (publ)

Extraordinary general meeting March 26, 2020

Notice of extraordinary general meeting of Xspray Pharma AB (publ)
The Board of Directors of Xspray Pharma AB (publ) proposal for warrant programme_LTI 2020-2023
Terms and conditions of the LTI 2020-2023
The Board´s statement in accordance with Chapter 14 Section 8 of the Swedish Companies Act
Auditors opinion under Chapter 14 Section 8 of the Swedish Companies Act
AGM 2020 – Proxy form
Minutes EGM 2020 03 26

Annual general meeting 23 May 2019

Notice of annual general meeting of Xspray Pharma AB (publ)
AGM 2019 – Proxy form
The nomination committee’s proposal and motivated statement

Extraordinary general meeting November 28 2018

Xspray Pharma – Notice EGM 2018[1]
EGM 2018 Fullmaktsformulär Eng – Proxy-form
XSpray Pharma – Terms and conditions of the warrants
The Board´s statement in accordance with Chapter 14 Section 8 of the Swedish Companies Act
Auditors Opinion under Chapter 14 Section 8 of the Swedish Companies Act

Annual general meeting May 14 2018

Notice to Annual General Meeting in Xspray Pharma AB (publ)
AGM_2018 – Proxy form

Extraordinary general meeting February 20 2018

Notice of extraordinary general meeting in Xspray Pharma AB (publ) February 20
The Board of Directors’ statement in accordance with Chapter 13 Section 6 of the Swedish Companies Act
Auditor’s opinion under Chapter 13 Section 6 the Companies Act (2005: 551) on the Board of Directorss statement of significant events for the period 2017-03-31 – 2018-01-30
The Board of Director’s of Xspray Pharma AB (publ) proposal for a resolution on a directed issue of shares
Proxy form